EXECUTIVE CHAIRMAN’S AGREEMENTExecutive Chairman's Agreement • May 12th, 2015 • Volitionrx LTD • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledMay 12th, 2015 Company Industry JurisdictionThis EXECUTIVE CHAIRMAN’S AGREEMENT is dated March 31, 2015 (the “Agreement”) by and between VOLITIONRX LIMITED, a Delaware corporation (the “Company”), and DR. MARTIN CHARLES FAULKES, an individual resident in the United Kingdom (“Dr. Faulkes”).
FIRST AMENDMENT TO EXECUTIVE CHAIRMAN’S AGREEMENTExecutive Chairman's Agreement • May 13th, 2016 • Volitionrx LTD • In vitro & in vivo diagnostic substances
Contract Type FiledMay 13th, 2016 Company IndustryThis First Amendment to Executive Chairman’s Agreement (the “Amendment”) is dated this 11th day of May 2016 between VolitionRx Limited, a Delaware corporation (the “Company”), and Dr. Martin Charles Faulkes, an individual resident in the United Kingdom (“Dr. Faulkes”).